Search results
Results from the WOW.Com Content Network
Soluble guanylate cyclase (sGC) stimulators are a class of drugs developed to treat heart failure, pulmonary hypertension, and other diseases.The first-in-class medication was riociguat, approved in 2013 for pulmonary hypertension.
In January 2020, the organization rebranded to its current name, Association of Diabetes Care and Education Specialists. [ 2 ] ADCES represents and supports diabetes educators by providing members with the resources to stay abreast of the current research, methods and trends in the field and by offering opportunities to network and collaborate ...
The main goal of diabetes management is to keep blood glucose (BG) levels as normal as possible. [1] If diabetes is not well controlled, further challenges to health may occur. [1] People with diabetes can measure blood sugar by various methods, such as with a BG meter or a continuous glucose monitor, which monitors over several days. [2]
Type 2 diabetes is the most common type of diabetes. Treatments include agents that (1) increase the amount of insulin secreted by the pancreas, (2) increase the sensitivity of target organs to insulin, (3) decrease the rate at which glucose is absorbed from the gastrointestinal tract, and (4) increase the loss of glucose through urination.
The Mayo Clinic generally recommends that diabetics who use insulin (all type 1 diabetics and many type 2 diabetics) test their blood sugar more often (4–8 times per day for type 1 diabetics, 2 or more times per day for type 2 diabetics), [1] both to assess the effectiveness of their prior insulin dose and to help determine their next insulin ...
International Diabetes Center at Park Nicollet (IDC) is a center for diabetes care, research and education located in Minneapolis, Minnesota, United States. The center provides clinical, motivational and educational services for people with diabetes.
For example, a single dose of raw cinnamon before a meal containing complex carbohydrates decreases the postprandial hyperglycemia (higher than 140 mg/dL; >7.8 mmol/L) in patients with type II diabetes. [51] Severe hyperglycemia can be treated with oral hypoglycemic therapy and lifestyle modification. [52]
The medication adherence of diabetes patients is also measured by persistence which is defined by the proportion of patients who remained in treatment for a predetermined period and the mean number of days till discontinuation of treatment. [15] The persistence rates ranged from 16% to 63% at 12 months and ranged from 29% to 70%. [14]